Modelling the impact of respiratory syncytial virus (RSV) vaccine and immunoprophylaxis strategies in New Zealand. (2021)

First Author: Prasad N
Attributed to:  MRC Centre for Global Infectious Disease Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2021.05.100

PubMed Identifier: 34147296

Publication URI: http://europepmc.org/abstract/MED/34147296

Type: Journal Article/Review

Volume: 39

Parent Publication: Vaccine

Issue: 31

ISSN: 0264-410X